• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
Argentina Pharmaceuticals and Healthcare Report Q1 2010 - Product Image

Argentina Pharmaceuticals and Healthcare Report Q1 2010

  • ID: 1095798
  • November 2009
  • Region: Argentina
  • 89 Pages
  • Business Monitor International

FEATURED COMPANIES

  • Boehringer Ingelheim
  • GlaxoSmithKline (GSK)
  • Indigenous Manufacturers
  • Laboratorios Bagó
  • Laboratorios Roemmers
  • Merck & Co
  • MORE

Argentina Pharmaceuticals and Healthcare Report provides industry professionals and strategists, corporate analysts, pharmaceutical associations, government departments and regulatory bodies with independent forecasts and competitive intelligence on Argentina's pharmaceuticals and healthcare industry.

The value of Argentina’s pharmaceutical market in 2008 was US$3.7bn. These updated forecasts see the market reaching a value of US$6.12bn by 2014, representing a compound annual growth rate (CAGR) of 12.68% in US dollar terms. With Argentina’s economy bouncing back after the economic crisis at the beginning of the decade, we expect the total value of the drug market to reach US$9.3bn by 2019.

However, the deep global recession has had a short-term impact on drug expenditure in Argentina, as out-of-pocket spending and government finances were hit, and the Argentine peso was devalued. Indeed, in 2009 we forecast that the drug sector will shrink by 10% in US dollar terms before recovering in 2010. However, the long-term fundamentals of the market remain strong, and in the authors opinion Argentina is one of the most promising pharmaceutical markets in Latin America READ MORE >

Note: Product cover images may vary from those shown

FEATURED COMPANIES

  • Boehringer Ingelheim
  • GlaxoSmithKline (GSK)
  • Indigenous Manufacturers
  • Laboratorios Bagó
  • Laboratorios Roemmers
  • Merck & Co
  • MORE

Executive Summary

SWOT Analysis
Argentina Pharmaceuticals And Healthcare Industry SWOT
Argentina Political SWOT
Argentina Economic SWOT
Argentina Business Environment SWOT

Pharmaceutical Business Environment Ratings
Table: Americas Regional Business Environment Ratings, Q110
Limits Of Potential Returns
Risks To Realisation Of Returns

Argentina – Market Summary

Regulatory Regime
OTC Regulation
Recent Regulatory Developments
Intellectual Property (IP) Environment
IP Disputes
Table: Joint Declaration By Latin American Health Ministers, May 2006
Counterfeit Pharmaceuticals
Pricing Regime
Table Argentina - Pharmaceutical Price Build-Up
Table: Argentina’s Drug Price Freeze, 2005-2008
Reimbursement Regime

Industry Trends And Developments
Epidemiology
Healthcare Insurance
Recent Healthcare Insurance Developments
Domestic Pharmaceutical Sector
Recent Developments in Domestic Pharmaceuticals Sector
Multinational Sector Developments
Vaccines Sector
Recent Developments in the Vaccines Sector
Pharmaceutical Wholesale Sector
Retail Pharmacy Sector
Medicinal Plants
Table Argentina - Imports of Medicinal Plants by Country (US$’000)
Research and Development (R&D)
Clinical Trials
Medical Devices

Industry Forecast Scenario
Overall Market Forecast
Key Growth Factors – Industry
Key Growth Factors – Macroeconomic
Table: Argentina - Economic Activity, 2006 – 2013
Prescription Drug Market Forecast
Patented Product Market Forecast
Generics Drug Market Forecast
OTC Medicine Market Forecast
Pharmaceutical Trade Forecasts
Table Argentina – Imports of Medicines Containing Vitamins by Country (US$’000)
Key Risks To BMI’s Forecast Scenario

Competitive Landscape

Company Monitor
Leading Foreign Companies
Pfizer
Roche
Novartis
GlaxoSmithKline (GSK)
Sanofi-Aventis
Merck & Co
Boehringer Ingelheim
Indigenous Manufacturers
Laboratorios Roemmers
Laboratorios Bagó

Country Snapshot: Argentina Demographic Data
Section 1: Population
Table: Demographic Indicators, 2005-2030
Table: Rural/Urban Breakdown, 2005-2030
Section 2: Education And Healthcare
Table: Education
Table: Life Expectancy, 2005-2030
Section 3: Labour Market And Spending Power
Table: Employment Indicators, 2001-2006
Table: Consumer Expenditure, 2000-2012 (US$)
Table: Average Annual Manufacturing Wages, 1995-2001

Methodology
How We Generate Our Pharmaceutical Industry Forecasts
Pharmaceutical Business Environment Ratings Methodology
Ratings Overview
Table: Pharmaceutical Business Environment Indicators
Weighting
Table: Weighting Of Components
Sources

Forecast Tables

Note: Product cover images may vary from those shown

- Pfizer
- Roche
- Novartis
- GlaxoSmithKline (GSK)
- Sanofi-Aventis
-Merck & Co
-Boehringer Ingelheim
- Indigenous Manufacturers
- Laboratorios Roemmers
- Laboratorios Bagó

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos